Table 2.

Effect of myricitrin and its SLN on intake, output, antioxidant, lipid peroxidation, and weight of the kidney

Groups	Kidney weight (g)	Water intake (ml)	Food intake (g)	Urine volume (ml)
Control	0.184±0.007	9.05±0.37	5.31±0.18	0.666±0.016
Vehicle	0.182±0.004**	9.40±0.36*	5.37±0.19**	0.660±0.018**
Diabetes	0.209±0.007##	10.58±0.31#	6.66±0.48##	0.780±0.020##
Diabetes + myricitrin 1 mg/kg	0.183±0.006**	9.10±0.42*	5.45±0.31**	0.687±0.023**
Diabetes + myricitrin 3 mg/kg	0.185±0.005**	8.77±0.43*	5.78±0.13**	0.700±0.018**
Diabetes + myricitrin 10 mg/kg	0.183±0.009**	8.25±0.32**	5.68±0.17**	0.687±0.024**
Diabetes + myricitrin SLN 1 mg/kg	0.180±0.006**	8.50±0.27**	5.13±0.13***	0.650±0.028**
Diabetes + myricitrin SLN 3 mg/kg	0.182±0.004*	8.40±0.41**	5.01±0.21***	0.688±0.023**
Diabetes + myricitrin SLN 10 mg/kg	0.187±0.009**	8.22±0.40**	4.96±0.33***	0.640±0.018***

Data are presented as mean±SEM; n=12; #P<0.05, ##P<0.01 and ###P<0.001 compared to the control, *P<0.05, **P<0.01, and ***P<0.001 compared to the diabetes group. SLN: Solid lipid nanoparticle